CD44 and breast carcinoma: CD44 or CD44-like receptors are significantly over-expressed in different solid tumors, including lung cancer, pancreatic cancer, and breast cancer, thus, tremendous efforts have been focused on studying the diagnostic and prognostic value of CD44, and particularly CD44v isoforms, in cancer.